No takes yet. Share an insight, caveat, or question.
Standardized 3D bioprinted models predict drug responses in breast cancer, suggesting improved therapeutic evaluations.
Petővári et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: